GR Engineering secures $229M Genesis Minerals deal
GR Engineering Services (ASX:GNG) finalises a $229 million EPC contract with Genesis Minerals (ASX:GMD) for the Tower Hill Gold Project.

TV presenter and finance editor at Grafa, with a Master’s in Commerce from UWA and diverse industry experience in finance, insurance, and media.
GR Engineering Services (ASX:GNG) finalises a $229 million EPC contract with Genesis Minerals (ASX:GMD) for the Tower Hill Gold Project.
Glassnode said nearly 10% of the total Bitcoin supply is structurally exposed to potential future quantum computing attacks because certain address types reveal public keys by design.
Fireblocks has launched Agentic Payments Suite and joined the x402 Foundation as the company expands its infrastructure business around AI-driven stablecoin payments.
Hillgrove Resources (ASX:HGO) and Havilah Resources (ASX:HAV) have entered into a binding farm-in agreement to develop the Mutooroo Copper Project.
Full Truck Alliance (NYSE:YMM) reported a 5.5% increase in first-quarter revenue for 2026, driven by a double-digit expansion in shipping volumes and robust user acquisition on its digital platform, though net profit figures retreated from the prior year's levels.
European crypto exchange WhiteBIT has launched whitebit.uk for UK retail and institutional users, adding GBP trading and Faster Payments Service funding as competition intensifies in Britain’s regulated crypto market.
Australian Agricultural Company (ASX:AAC) has delivered a stellar FY26 financial performance, headlined by an operating profit of $71.6 million.
Oil prices dropped sharply on Wednesday, recording their largest single-day decline in over a month. The selloff was triggered by comments from President Donald Trump indicating that the United States is close to finalizing a diplomatic agreement with Iran, alongside real-time maritime tracking data showing a tentative resumption of oil tanker traffic through the critical Strait of Hormuz.
Medtronic (NYSE:MDT) announced a definitive agreement to acquire SPR Therapeutics, a privately held medical technology company specializing in temporary peripheral nerve stimulation (PNS) therapies for chronic pain management.
Roivant Sciences (NASDAQ:ROIV) reported a return to profitability for its fourth fiscal quarter ended March 31, 2026, reversing a prior-year loss due to a substantial non-recurring gain stemming from the resolution of its global patent infringement dispute with Moderna.